New cancer combo aims to spare patients from permanent colostomy bags
NCT ID NCT07277842
Summary
This study is testing whether adding an immunotherapy drug (PD-1 antibody) to strong chemotherapy and radiation before surgery works better than standard chemotherapy with radiation for adults with advanced rectal cancer. Researchers want to see if this approach helps more patients avoid permanent colostomy bags and live longer without cancer returning. The trial will involve 382 participants randomly assigned to receive either the experimental combination or the standard treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED LOW RECTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sun Yat-Sen University Cancer Center
Guangzhou, None Selected, 510060, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.